Researcher Portfolio
Sperling, Swetlana
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society
Researcher Profile
Position: Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society
Researcher ID: https://pure.mpg.de/cone/persons/resource/persons182422
External references
WorldCat
Search for Sperling, Swetlana
Google Scholar
Search for Sperling, Swetlana
Publications
: Hassouna, I., Ott, C., Wüstefeld, L., Offen, N., Neher, R. A., Mitkovski, M., Winkler, D., Sperling, S., Fries, L., Goebbels, S., Vreja, I. C., Hagemeyer, N., Dittrich, M., Rossetti, M. F., Kröhnert, K., Hannke, K., Boretius, S., Zeug, A., Höschen, C., Dandekar, T., Dere, E., Neher, E., Rizzoli, S. O., Nave, K.-A., Sirén, A.-L., & Ehrenreich, H. (2016). Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampus. Molecular Psychiatry, 21(12), 1752-1767. doi:10.1038/mp.2015.212. [PubMan] : Hammer, C., Stepniak, B., Schneider, A., Papiol, S., Tantra, M., Begemann, M., Sirén, A.-L., Pardo, L. A., Sperling, S., Mohd Jofrry, S., Gurvich, A., Jensen, N., Ostmeier, K., Lühder, F., Probst, C., Martens, H., Gillis, M., Saher, G., Assogna, F., Spalletta, G., Stöcker, W., Schulz, T. F., Nave, K.-A., & Ehrenreich, H. (2014). Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Molecular Psychiatry, 19(10), 1143-1149. doi:10.1038/mp.2013.110. [PubMan] : Steinberg, S., de Jong, S., Mattheisen, M., Costas, J., Demontis, D., Jamain, S., Pietiläinen, O. P. H., Lin, K., Papiol, S., Huttenlocher, J., Sigurdsson, E., Vassos, E., Giegling, I., Breuer, R., Fraser, G., Walker, N., Melle, I., Djurovic, S., Agartz, I., Tuulio-Henriksson, A., Suvisaari, J., Lönnqvist, J., Paunio, T., Olsen, L., Hansen, T., Ingason, A., Pirinen, M., Strengman, E., Hougaard, D. M., Ørntoft, T., Didriksen, M., Hollegaard, M. V., Nordentoft, M., Abramova, L., Kaleda, V., Arrojo, M., Sanjuán, J., Arango, C., Etain, B., Bellivier, F., Méary, A., Schürhoff, F., Szoke, A., Ribolsi, M., Magni, V., Siracusano, A., Sperling, S., Rossner, M., Christiansen, C., Kiemeney, L. A., Franke, B., van den Berg, L. H., Veldink, J., Curran, S., Bolton, P., Poot, M., Staal, W., Rehnstrom, K., Kilpinen, H., Freitag, C. M., Magnusson, P., Saemundsen, E., Martsenkovsky, I., Bikshaieva, I., Martsenkovska, I., Vashchenko, O., Raleva, M., Paketchieva, K., Stefanovski, B., Durmishi, N., Pejovic Milevancevic, M., Lecic Tosevski, D., Silagadze, T., Naneishvili, N., Mikeladze, N., Surguladze, S., Vincent, J. B., Farmer, A., Mitchell, P. B., Wright, A., Schofield, P. R., Fullerton, J. M., Montgomery, G. W., Martin, N. G., Rubino, I. A., van Winkel, R., Kenis, G., De Hert, M., Réthelyi, J. M., Bitter, I. I., Terenius, L., Jönsson, E. G., Bakker, S., van Os, J., Jablensky, A., Leboyer, M., Bramon, E., Powell, J., Murray, R., Corvin, A., Gill, M., Morris, D., O'Neill, F. A., Kendler, K., Riley, B., Wellcome Trust Case Control Consortium, Craddock, N., Owen, M. J., O'Donovan, M. C., Thorsteinsdottir, U., Kong, A., Ehrenreich, H., Carracedo, A., Golimbet, V., Andreassen, O. A., Børglum, A. D., Mors, O., Mortensen, P. B., Werge, T., Ophoff, R. A., Nöthen, M. M., Rietschel, M., Cichon, S., Ruggeri, M., Tosato, S., Palotie, A., St Clair, D., Rujescu, D., Collier, D. A., Stefansson, H., & Stefansson, K. (2014). Common variant at 16p11.2 conferring risk of psychosis. Molecular Psychiatry, 19(1), 108-114. doi:10.1038/mp.2012.157. [PubMan] : El-Kordi, A., Kästner, A., Grube, S., Klugmann, M., Begemann, M., Sperling, S., Hammerschmidt, K., Hammer, C., Stepniak, B., Patzig, J., Monasterio-Schrader, P. d., Strenzke, N., Flügge, G., Werner, H. B., Pawlak, R., Nave, K.-A., & Ehrenreich, H. (2013). A single gene defect causing claustrophobia. Translational Psychiatry, 3: e254. doi:10.1038/tp.2013.28. [PubMan] : Kästner, A., Grube, S., El-Kordi, A., Stepniak, B., Friedrichs, H., Sargin, D., Schwitulla, J., Begemann, M., Giegling, I., Miskowiak, K. W., Sperling, S., Hannke, K., Ramin, A., Heinrich, R., Gefeller, O., Nave, K.-A., Rujescu, D., & Ehrenreich, H. (2012). Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophrenia. Molecular Medicine, 18, 1029-1040. doi:10.2119/molmed.2012.00190. [PubMan] : Hagemeyer, N., Boretius, S., Ott, C., Streitberg, A. v., Welpinghus, H., Sperling, S., Frahm, J., Simons, M., Ghezzi, P., & Ehrenreich, H. (2012). Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice. Molecular Medicine, 18(4), 628-635. doi:10.2119/molmed.2011.00457. [PubMan] : Ehrenreich, H., Kästner, A., Weissenborn, K., Streeter, J., Sperling, S., Wang, K. K., Worthmann, H., Hayes, R. L., Ahsen, N. v., Kastrup, A., Jeromin, A., & Herrmann, M. (2011). Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patients. Molecular Medicine, 17(11-12), 1306-1310. doi:10.2119/molmed.2011.00259. [PubMan] : Steinberg, S., Jong, S. d., Andreassen, O., Werge, T., Børglum, A. D., Mors, O., Mortensen, P. B., Gustafsson, O., Costas, J., Pietiläinen, O. P. H., Demontis, D., Papiol, S., Huttenlocher, J., Mattheisen, M., Breuer, R., Vassos, E., Giegling, I., Fraser, G., Walker, N., Tuulio-Henriksson, A., Suvisaari, J., Lönnqvist, J., Paunio, T., Agartz, I., Melle, I., Djurovic, S., Strengman, E., Jürgens, G., Glenthøj, B., Terenius, L., Hougaard, D. M., Ørntoft, T., Wiuf, C., Didriksen, M., Hollegaard, M. V., Nordentoft, M., Winkel, R. v., Kenis, G., Abramova, L., Kaleda, V., Arrojo, M., Sanjuán, J., Arango, C., Sperling, S., Rossner, M., Ribolsi, M., Magni, V., Siracusano, A., Christiansen, C., Kiemeney, L. A., Veldink, J., Van den Berg, L., Ingason, A., Muglia, P., Murray, R., Nöthen, M. M., Sigurdsson, E., Petursson, H., Thorsteinsdottir, U., Kong, A., Rubino, I. A., Hert, M. d., Réthelyi, J. M., Bitter, I., Jönsson, E. G., Golimbet, V., Carracedo, A., Ehrenreich, H., Craddock, N., Owen, M. J., O'Donovan, M. C., Ruggeri, M., Tosato, S., Peltonen, L., Ophoff, R. A., Collier, D. A., St Clair, D., Rietschel, M., Cichon, S., Stefansson, H., Rujescu, D., & Stefansson, K. (2011). Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Human Molecular Genetics, 20(20), 4076-4081. doi:10.1093/hmg/ddr325. [PubMan] : Papiol, S., Malzahn, D., Kästner, A., Sperling, S., Begemann, M., Stefansson, H., Bickeböller, H., Nave, K.-A., & Ehrenreich, H. (2011). Dissociation of accumulated genetic risk and disease severity in patients with schizophrenia. Translational Psychiatry, e45. doi:10.1038/tp.2011.43. [PubMan] : Ribbe, K., Ackermann, V., Schwitulla, J., Begemann, M., Papiol, S., Grube, S., Sperling, S., Friedrichs, H., Jahn, O., Sillaber, I., Gefeller, O., Krampe, H., & Ehrenreich, H. (2011). Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system. Archives of General Psychiatry, 68(12), 1247-1256. doi:10.1001/archgenpsychiatry.2011.100. [PubMan] : Sargin, D., El-Kordi, A., Agarwal, A., Müller, M., Wojcik, S. M., Hassouna, I., Sperling, S., Nave, K.-A., & Ehrenreich, H. (2011). Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice. BMC Biology, 9: 27. doi:10.1186/1741-7007-9-27. [PubMan] : Begemann, M., Grube, S., Papiol, S., Malzahn, D., Krampe, H., Ribbe, K., Friedrichs, H., Radyushkin, K. A., El-Kordi, A., Benseler, F., Hannke, K., Sperling, S., Schwerdtfeger, D., Thanhäuser, I., Gerchen, M. F., Ghorbani, M., Gutwinski, S., Hilmes, C., Leppert, R., Ronnenberg, A., Sowislo, J., Stawicki, S., Stödtke, M., Szuszies, C., Reim, K., Riggert, J., Eckstein, F., Falkai, P., Bickeböller, H., Nave, K.-A., Brose, N., & Ehrenreich, H. (2010). Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Archives of General Psychiatry, 67(9), 879-888. doi:10.1001/archgenpsychiatry.2010.107. [PubMan] : Adamcio, B., Sperling, S., Hagemeyer, N., Walkinshaw, G., & Ehrenreich, H. (2010). Hypoxia inducible factor stabilization leads to lasting improvement of hippocampal memory in healthy mice. Behavioural Brain Research, 208(1): 10.1016/j.bbr.2009.11.010, pp. 80-84. doi:10.1016/j.bbr.2009.11.010. [PubMan] : Binder, C., Hagemann, T., Sperling, S., Schulz, M., Pukrop, T., Grimshaw, M. J., & Ehrenreich, H. (2009). Stromal endothelin B receptor-deficiency inhibits breast cancer growth and metastasis. Molecular Cancer Therapeutics, 8(8), 2452-2460. doi:10.1158/1535-7163.MCT-09-0032. [PubMan] : Sargin, D., Hassouna, I., Sperling, S., Sirén, A.-L., & Ehrenreich, H. (2009). Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion. GLIA, 57(7), 693-702. doi:10.1002/glia.20797. [PubMan] : Adamcio, B., Sargin, D., Stradomska, A., Medrihan, L., Gertler, C., Theis, F., Zhang, M., Müller, M., Hassouna, I., Hannke, K., Sperling, S., Radyushkin, K., El-Kordi, A., Schulze, L., Ronnenberg, A., Wolf, F., Brose, N., Rhee, J.-S., Zhang, W., & Ehrenreich, H. (2008). Erythropoietin enhances hippocampal long-term potentiation and memory. BMC Biology, 6: 37. doi:10.1186/1741-7007-6-37. [PubMan] : Hassouna, I., Sperling, S., Kim, E., Schulz-Schaeffer, W., Rave-Fränk, M., Hasselblatt, M., Jelkmann, W., Giese, A., & Ehrenreich, H. (2008). Erythropoietin augments survival of glioma cells after radiation and temozolomide. International Journal of Radiation Oncology, Biology, Physics, 72(3), 927-934. doi:10.1016/j.ijrobp.2008.06.1923. [PubMan] : Begemann, M., Sargin, D., Rossner, M. J., Bartels, C., Theis, F., Wichert, S. P., Stender, N., Fischer, B., Sperling, S., Stawicki, S., Wiedl, A., Falkai, P., Nave, K.-A., & Ehrenreich, H. (2008). Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches. Molecular Medicine, 14(9-10), 546-552. doi:10.2119/2008-00053.Begemann. [PubMan] : Weishaupt, J. H., Bartels, C., Pölking, E., Dietrich, J., Rohde, G., Poeggeler, B., Mertens, N., Sperling, S., Bohn, M., Hüther, G., Schneider, A., Bach, A., Sirén, A.-L., Hardeland, R., Bähr, M., Nave, K.-A., & Ehrenreich, H. (2006). Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. Journal of Pineal Research, 41(4), 313-323. doi:10.1111/j.1600-079X.2006.00377.x. [PubMan] : Sirén, A.-L., Radyushkin, K., Boretius, S., Kämmer, D., Riechers, C.-C., Natt, O., Sargin, D., Watanabe, T., Sperling, S., Michaelis, T., Price, J., Meyer, B., Frahm, J., & Ehrenreich, H. (2006). Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. Brain, 129, 480-489. doi:10.1093/brain/awh703. [PubMan] : Ehrenreich, H., Hasselblatt, M., Knerlich, F., von Ahsen, N., Jacob, S., Sperling, S., Woldt, H., Vehmeyer, K., Nave, K.-A., & Sirén, A.-L. (2005). A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proceedings of the National Academy of Sciences of the United States of America, 102(3), 862-867. doi:10.1073/pnas.0406008102. [PubMan]